Barry E. Greene, Director at ACORDA THERAPEUTICS INC (ACOR), sold 6,034 shares at $19.26 ($116K) on 2017-01-03, disclosed to the SEC on 2017-01-05.
Open-market sale of $116k ACOR by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.26 | 3,017 | $58K | 50.0% |
| 2 | $19.26 | 3,017 | $58K | 50.0% |
| Total | $19.26 avg | 6,034 | $116K | 100% |
| Filing → |
| SAGE | BUY | 2021-06-17 | $496K | — | Filing → |
| ALNY | SELL | 2020-09-11 | $11.0M | — | Filing → |
| ALNY | SELL | 2020-07-09 | $7.1M | — | Filing → |